is tirzepatide a glp-1 agonist Tirzepatide, dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Tirzepatide 10mg – Dual GIP/GLP-1

Peptides: Most peptides can be run longer and with more flexibility, but be smart: GH secretagogues (Ipamorelin, CJC-1295) use cycling or periodic breaks to avoid desensitization

The dose may then be increased in at least 4-week intervals up to the maximum dose of 15mg once weekly, if recommended by a doctor

Int J Obes 40(9):13691375

Together, these findings demonstrate that dual targeting of the immune axis (aCD3) and the beta cell axis (GLP1-E2) preserves functional beta cell mass in vivo by preventing beta cell dedifferentiation and death, without altering beta cell proliferation

1 The dual-agonist mechanism offers a strong potential for enhanced results, but it is not a promise for every person

Features: Achieve a natural-looking tan without the effects of the sun